Business alliance in and outside of Japan is an important business strategy for LTL Pharma.
LTL Pharma proactively seeks an opportunity of alliance with other pharmaceutical company to develop business both in Japan and overseas. We continue to make efforts to enrich our portfolio of long-life medicines going forward through transfer of marketing authorizations as well as distribution from other companies.
Adding new therapeutic areas to the primary care focused in the current portfolio, we aim to expand our future portfolio and further develop overseas business with these products as well.
LTL Pharma also strengthens alliance for active pharmaceutical ingredients and other ingredients to ensure even more stable supply.
Alliances in Japan
Transfer of Marketing authorization and
Marketing authorization transfer of 16 products from Astellas Pharma Inc.